Analyst Price Target is $37.15
▲ +104.70% Upside Potential
This price target is based on 13 analysts offering 12 month price targets for Phreesia in the last 3 months. The average price target is $37.15, with a high forecast of $43.00 and a low forecast of $29.00. The average price target represents a 104.70% upside from the last price of $18.15.
Current Consensus is
The current consensus among 13 polled investment analysts is to moderate buy stock in Phreesia. This Moderate Buy consensus rating has held steady for over two years.
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Wilmington, Delaware.